MedPath

Management of Rapid Heart Rate in Patients With Atrial Fibrillation/Flutter and Left Ventricular Dysfunction -Randomized Controlled Trial of Landiolol vs. Diltiazem

Not Applicable
Conditions
Heart failure, Atrial Fibrillation/Flutter
Registration Number
JPRN-UMIN000015053
Lead Sponsor
Kurashiki Central Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

The main exclusion criteria were: necessity for electrical cardioversion; serious valve stenosis; confirmed or suspected hyperthyroidism; implantable cardiac pacemaker and/or implantable defibrillator; necessity for mechanical ventilation; and cardiogenic shock (systolic blood pressure (BP) <90 mmHg).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath